Publications
Specialty Tier-Level Cost Sharing and Biologic Use in the Medicare Part D Initial Coverage Period among Beneficiaries with Rheumatoid Arthritis. Doshi, J. A.,Hu, T.,Li, P.,Pettit, A. R.,Yu, X.,Blum, M.; Arthritis Care Res (Hoboken). 1900 Jan 01.
Patient race and surgical outcomes after total knee arthroplasty: An analysis of a large regional database.
Blum, M. A.,Singh, J. A.,Lee, G. C.,Richardson, D.,Chen, W.,Ibrahim, S. A.; Arthritis Care Res (Hoboken). 2013 Mar.
Race/Ethnicity and use of elective joint replacement in the management of end-stage knee/hip osteoarthritis: a review of the literature. Blum, M. A., Ibrahim, S. A.; Clin Geriatr Med. 2012 Aug.
Measurement and Rates of Persistence With and Adherence to Biologics for Rheumatoid Arthritis: A Systematic Review. Blum, M.A., Koo, D., Doshi, J.A.; Clin Ther. 2011 Jul.
Adherence, discontinuation, and switching of biologic therapies in medicaid enrollees with rheumatoid arthritis. Li, P., Blum, M.A., Von Feldt, J., Hennessy, S., Doshi, J.A.; Value Health. 2010-09-01.
Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Fackler, M.J., McVeigh, M., Mehrotra, J., Blum, M.A., Lange, J., Lapides, A., Garrett, E., Argani, P., Sukumar, S.; Cancer Res. 2004 Jul 1.
Patient Comments